Our platform of infusion temperature control is developing with ongoing input and tradeoff analysis from numerous military clinicians and stakeholders to deliver a usable product for all echelons of care. Participants in this process have included ISR researchers, USAMRMC combat casualty care, SOF medical directorate, SOF command surgeon, SOF medics and physicians, and civilian DARPA funded researchers.
We strongly believe that to field the best solutions to a clinical problem, the starting point is end user feedback at the infancy of development. Our technology reflects that and is essentially invisible to the user. Unlike the numerous cumbersome and impractical to carry commercially available fluid warmers our technology architecture incorporated advanced technology into seemingly conventional appearing intravenous infusion tubing.
Our platform will be the first device to enable both warming and cooling of intravenous fluids and blood products when and anywhere they are indicated. Including the most far forward environments.
Please read on for further discussion of this technology in Combat Care
If you wish to communicate directly with our Chief Medical Officer, Click Here.
Inducing Therapeutic Hypothermia with chilled IV fluids
The second goal of the platform under development is to also allow immediate point of contact induction of TH by infusing a quantity of crystalloid solution chilled to 4oC. In an average size adult, hypothermia induction can typically be achieved by a bolus of 30cc/kg (maximum of 2 liters) of chilled normal saline given at a rate of 100cc/minute. Read More.
The safety of blood products in infusion warmers and freeze dried plasma
Recent studies have called attention to the safety and efficacy of blood products that have been stored beyond 30 days. Infusion of these older blood products is associated with much higher morbidity and mortality than “fresher” blood products. Read More.